RE: SNG Covid Business Model25 Nov 2020 09:25
Tiger - 100,000 courses at $3000+ per course ($300,000,000 per MONTH income, $3.6bn PA). You wouldn't ramp up production to that level without a clear pathway to getting these into governments hands.
We have 200m shares - surely the mkt cap will be somewhere near the $3.6bn? That's around $18 a share (£13.50 ish). It is possible, assuming P3 trials are successful.
The market is fickle, so gives us lots of opportunities to buy. That's the market.
Add to that COPD in the future a massive market.....and we will have the money to progress all the trials on that through to market.
I say again, people need to amend their lens. Think longer than a week...month or quarter. Think next year.